An interview with Wataru Akahata, CEO of VLP Therapeutics (VLPT) and VLPT Japan, has been featured in the latest issue of WIRED magazine and on its online edition.
“Vaccine development is incredibly hard, but once realized, it can protect far more lives more affordably than surgery. That’s what makes it so vital,” said Wataru Akahata in the interview.
Source:
- WIRED (Japan), published June 4, 2026 (online) : “Opening New Paths for Vaccine Development from Japan: Portraits of Four Pioneers Rewriting the Future of Global Health” (in Japanese)
- WIRED (Japan), Vol 59, pp 126–127, published Apr 22, 2026 (print): “Reframing Futures of Global Health | Engineering Immunity” (in Japanese)